214 related articles for article (PubMed ID: 5296835)
1. The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat.
Lewis JJ; Ritchie AP; van Petten GR
Br J Pharmacol Chemother; 1965 Dec; 25(3):631-7. PubMed ID: 5296835
[No Abstract] [Full Text] [Related]
2. [Halluciogenic substances and sleep mechanisms].
Rougeul A; Verdeaux J
Rev Can Biol; 1972; 31():Suppl:49-58. PubMed ID: 4538208
[No Abstract] [Full Text] [Related]
3. [Pharmacological action spectra of hallucinogens].
Waser PG
Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
[No Abstract] [Full Text] [Related]
4. Comparative effects of hallucinogenic drugs on behavior of the cat.
Jacobs BL; Trulson ME; Stark AD; Christoph GR
Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
[No Abstract] [Full Text] [Related]
5. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
Koerner J; Appel JB
Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
[TBL] [Abstract][Full Text] [Related]
6. Action of psychotogenic drugs on single midbrain raphe neurons.
Aghajanian GK; Foote WE; Sheard MH
J Pharmacol Exp Ther; 1970 Feb; 171(2):178-87. PubMed ID: 5459056
[No Abstract] [Full Text] [Related]
7. Inhibition of isolation-induced attack behavior of mice by drugs.
Uyeno ET
J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
[No Abstract] [Full Text] [Related]
8. Discriminable stimuli produced by hallucinogens.
Kuhn DM; White FJ; Appel JB
Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
[No Abstract] [Full Text] [Related]
9. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
10. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
Martin WR; Eades CG
Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
[No Abstract] [Full Text] [Related]
11. Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.
Dyer DC; Gant DW
J Pharmacol Exp Ther; 1973 Feb; 184(2):366-75. PubMed ID: 4347258
[No Abstract] [Full Text] [Related]
12. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Snyder SH; Faillace L; Hollister L
Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
[TBL] [Abstract][Full Text] [Related]
13. [Action of hallucinogens on electroencephalograms].
Oughourlian JM; Rougeul A; Verdeaux J
Therapie; 1971; 26(5):953-68. PubMed ID: 5160349
[No Abstract] [Full Text] [Related]
14. Hallucinogens and dominance behavior of the rat.
Uyeno ET
Proc West Pharmacol Soc; 1967; 10():94. PubMed ID: 6055511
[No Abstract] [Full Text] [Related]
15. Behavioural effects of some morphine antagonists and hallucinogens in the rat.
Schneider C
Nature; 1968 Nov; 220(5167):586-7. PubMed ID: 5686733
[No Abstract] [Full Text] [Related]
16. [Electrographic and behavioral effects of various hallucinogens in the free cat].
Rougeul A; Verdeaux J; Letalle A
Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
[No Abstract] [Full Text] [Related]
17. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
18. Psychedelic drugs and creativity.
Krippner S
J Psychoactive Drugs; 1985; 17(4):235-45. PubMed ID: 4087078
[No Abstract] [Full Text] [Related]
19. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
Stolk JM; Barchas JD; Goldstein M; Boggan W; Freedman DX
J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298
[No Abstract] [Full Text] [Related]
20. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
McCall RB; Aghajanian GK
Life Sci; 1980 Apr; 26(14):1149-56. PubMed ID: 7392793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
